Previous researches indicated that increased expression of galectin-3 often predicted unfavorable outcomes and the level of galectin-3 was positively correlated with invasion of depth, vessel invasion, lymph node metastasis, distant metastasis, and TNM stages of various cancers [26, 53]. This evidence concerns the gene LGALS3 and metastatic malignant neoplasm in the lymph nodes.